By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oncodesign SA 

20 rue Jean Mazen
B.P. 27627
Dijon  Cedex  21076  France
Phone: 33-3-80-78-82-60 Fax: 33-3-80-78-82-61




Company News
Oncodesign SA Presents Novel LRRK2 Inhibitor Jointly Discovered With Ipsen At The 2015 Neurosciences Meeting In Chicago 10/22/2015 11:17:57 AM
UCB Exercises Its Option To License A Program From Oncodesign SA Targeting Neurological Diseases 6/5/2015 9:31:36 AM
Oncodesign SA Has Entered Into A Services Agreement With Eisai Inc. (ESALF.PK) To Develop A New Personalized Medicine Program In Earlier Line Metastatic Breast Cancer Treatment 12/17/2014 11:44:28 AM
Oncodesign SA: 1st Half Of 2014 7/23/2014 12:33:03 PM
Oncodesign SA And UCB, Inc. (UCBJF.PK) Enter Into A Research Collaboration For The Early Development Of New Therapeutic Agents In Neurodegenerative Diseases 11/13/2013 9:06:53 AM
Oncodesign SA and Banook Central Imaging Sign a Collaboration Agreement to Develop Biomarkers in Clinical Imaging 9/9/2013 9:45:25 AM
Oncodesign SA Awarded Accreditation of Its Research Center by International Association, AAALAC 7/18/2013 9:34:11 AM
Oncodesign SA Signs a Partnership Agreement and an Option for Exclusive Licensing With Sanofi (France) (SAN.PA) in the Area of Tissue Protection and Repair 3/27/2013 12:09:21 PM
Oncodesign SA and OSEO, Winners of the IMODI Project From the French Government's Investing for the Future Program, Announce Funding of EUR 13.4 Million 3/13/2013 10:20:21 AM
Oncodesign SA and the Laboratory for Neurobiology and Gene Therapy at the KU Leuven Enter Into a Research Collaboration for Advancing Drug Discovery Efforts With Ipsen (IPN.PA) in Parkinson's Disease 12/18/2012 9:30:17 AM